CIK 0001582554 · Non-accelerated filer<br>Smaller reporting company
Matinas BioPharma Holdings, Inc.
Sign in to watch- Ticker
- MTNB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463011414
- Phone
- 908-484-8805
- Business address
- 1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-01 | CONRAD HERBERT J Director | Grant or award · Stock option (right to buy) | +437,244 | 437,244 | ||
| 2023-11-01 | Ende Eric J Director | Grant or award · Stock option (right to buy) | +437,244 | 437,244 | ||
| 2022-12-20 | Matkovits Theresa Chief Development Officer | Grant or award · Stock Option (right to Buy) | +625,000 | 625,000 | ||
| 2022-12-20 | Liu Hui Chief Technology Officer | Grant or award · Stock Option (right to Buy) | +625,000 | 625,000 | ||
| 2022-12-20 | Kucinski Keith A Chief Financial Officer | Grant or award · Stock Option (right to Buy) | +625,000 | 625,000 | ||
| 2022-12-20 | Jabbour Jerome D President and CEO | Grant or award · Stock Option (right to Buy) | +1,988,300 | 1,988,300 | ||
| 2022-12-20 | Hoover Thomas Chief Business Officer | Grant or award · Stock Option (right to Buy) | +475,000 | 475,000 | ||
| 2022-12-20 | Ferguson James J. III Chief Medical Officer | Grant or award · Stock Option (right to Buy) | +625,000 | 625,000 | ||
| 2022-11-14 | Giordano Natasha Director | Grant or award · Stock option (right to buy) | +142,657 | 142,657 | ||
| 2022-11-14 | Corzo Kathryn Penkus Director | Grant or award · Stock option (right to buy) | +142,657 | 142,657 | ||
| 2022-11-14 | CONRAD HERBERT J Director | Grant or award · Stock option (right to buy) | +142,657 | 142,657 | ||
| 2022-11-14 | WIKLER MATTHEW Director | Grant or award · Stock option (right to buy) | +142,657 | 142,657 | ||
| 2022-11-14 | Ende Eric J Director | Grant or award · Stock option (right to buy) | +142,657 | 142,657 | ||
| 2022-11-14 | Scibetta James S Director | Grant or award · Stock option (right to buy) | +142,657 | 142,657 | ||
| 2022-06-22 | CONRAD HERBERT J Director | Gift | −1,358,122 | 0 | ||
| 2022-06-22 | CONRAD HERBERT J Director | Gift | +1,358,122 | 4,694,566 | ||
| 2021-12-31 | WIKLER MATTHEW Director | Grant or award | +7,859 | 290,472 | ||
| 2021-12-14 | Jabbour Jerome D President and CEO | Grant or award · Stock Option (right to Buy) | +1,658,100 | 1,658,100 | ||
| 2021-12-14 | Kucinski Keith A Chief Financial Officer | Grant or award · Stock Option (right to Buy) | +500,000 | 500,000 | ||
| 2021-12-14 | Hui Liu Chief Technology Officer | Grant or award · Stock Option (right to Buy) | +275,000 | 275,000 |
Page 3 of 14 · 264 trades